BioInformant Worldwide, L.L.C.

Website Links

Description

How To Buy Formats & Delivery Terms & Conditions $ Back Guarantee Why BioInformant? FAQ's Our market reports emphasize rapidly changing trends within the life science industry and emphasize profitable opportunities that companies in this sector can pursue. We use proprietary search technologies to estimate market size, market share, market growth, and market patterns (cyclicity within a calendar year). To supplement the “hard ” data collected for each project, our market analysts add qualitative analysis to each report, providing a high-tech, high-touch result. Because we believe all customers should be repeat customers, all market reports are backed by a progressive 60-Day Money Back Guarantee . To serve of range of industry and government clients, reports can be purchased directly through this site, or alternatively, by fax, telephone, email or purchase order (P.O.). Click here for more information on purchasing. Capitalizing on Opportunities in Cord Blood Industry Growth NEW - Jan 2010! Over the past year, the cord blood banking industry expanded through double digit growth, due to new entrants to the industry, as well as revenue growth at existing operations. Deeper analysis revealed that most cord blood banks fall into one of two “camps, ” either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (at a rate of 17% or more per annum). This finding begs the questions: What factors caused a substantial number of new cord blood banks to open up business in 2009? What will be the effect of these new entrants for existing competitors? What are the differences among the cord blood banks that are experiencing flat-line vs. substantive growth? In addition, this report includes survey results from approximately 1,200 expectant parents. Statistical analysis of the results provide a roadmap for how cord blood banks can best communicate and market their services to potential clients. Opportunities in Human Embryonic Stem Cell (hESC) Products NEW - Dec 2009! hESCs have been proposed for a range of applications, including toxicology testing, tissue engineering, and cellular therapies. Currently, the Wisconsin Alumni Research Foundation (WARF) holds a series of landmark patents that have made it the “gatekeeper ” determining which research product companies have been allowed to create hESC products and what pharmaceutical companies have been able to develop hESC therapies. Since 1998, WARF has only entered into licensing agreements with 27 commercial partners. While Invitrogen, Becton Dickinson and Chemicon have disclosed licensing agreements with WARF, many research products companies have to explore less costly alternatives – such as circumventing claims, conducting research off-shore, using abnormal karyotypes, developing products for other species, or strategic collaborations. This report explores the complex IP landscape, as well as characterizes this rapidly growing market and the opportunities it presents.

Products & services

Similar companies nearby